COVID-19 Vaccination Booster Dose: Knowledge, Practices, and Intention among Pregnant/Planning to Get Pregnant and Lactating Women

Author:

Al-Qerem Walid1ORCID,Jarab Anan23,Shawabkeh Yara1,Ling Jonathan4ORCID,Hammad Alaa1ORCID,Alazab Badi’ah1ORCID,Alasmari Fawaz5ORCID

Affiliation:

1. Department of Pharmacy, AlZaytoonah University of Jordan, Amman 11733, Jordan

2. College of Pharmacy, Al Ain University, Abu Dhabi P.O. Box 64141, United Arab Emirates

3. Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan

4. Faculty of Science and Wellbeing, University of Sunderland, Sunderland SR1 3SD, UK

5. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 12372, Saudi Arabia

Abstract

Pregnant women are at higher risk of developing severe COVID-19 symptoms. Therefore, booster dose against COVID-19 was recommended for this special population in Jordan. However, vaccine hesitancy/refusal remains the main obstacle to providing immunity against the spread of COVID-19. Thus, the aim of this study is to examine the intention of pregnant/planning to get pregnant and lactating women towards receiving a booster dose against COVID-19 and its associated factors. A questionnaire was given to Jordanian pregnant/planning to get pregnant and lactating females. A total of 695 females were enrolled in the study. Older age, having a chronic disease, high education, high income, and high perceived risk of COVID-19 were significantly associated with higher knowledge about COVID-19. High perceived risk of COVID-19 was significantly associated with better practice. Participants who anticipated they might contract COVID-19 in the next six months, had high perceived risk of COVID-19, had high knowledge, had received the COVID-19 vaccine based on conviction, and smokers had higher intention to receive a booster dose of the COVID-19 vaccination. In order to increase pregnant and lactating women’s intention to receive a booster dose of the COVID-19 vaccine, public health organizations should consider developing comprehensive health education campaigns.

Funder

King Saud University

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference42 articles.

1. World Health Organization (2023, May 13). WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online: https://covid19.who.int.

2. World Health Organization (2023, May 13). Fighting COVID-19 Could Cost 500 Times as Much as Pandemic Prevention Measures. Strategic Partnership for Health Security and Emergency Preparedness (SPH) Portal. Available online: https://extranet.who.int/sph/fighting-covid-19-could-cost-500-times-much-pandemic-prevention-measures.

3. World Health Organization (2023, May 13). Therapeutics and COVID-19: Living Guideline, 13 January 2023. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1.

4. Hussein, T., Hammad, M.H., Fung, P.L., Al-Kloub, M., Odeh, I., Zaidan, M.A., and Wraith, D. (2021). COVID-19 Pandemic Development in Jordan-Short-Term and Long-Term Forecasting. Vaccines, 9.

5. Exploring the Reasons Behind Parental Refusal of Vaccines;McKee;J. Pediatr. Pharmacol. Ther. JPPT,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3